June 2, 2026
NewLimit
NewLimit is a biotech company developing epigenetic therapi
- Round
- Series C
- Amount raised
- $435M
- Lead investor
- Founders Fund
- Industry
- Biotechnology
- Headquarters
- South San Francisco, United States
- Employees
- 11-50
- Website
- www.newlimit.com
- —